Clinical Trial Update: Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated management of anemia and neutropenia in HIV/Hepatitis C coinfected patients treated with pegylated interferon and ribavirin; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a) (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Anemia, Neutropenia | Phase 4 | Status: TERMINATED